These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15203329)

  • 1. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
    Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
    Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanide-based luminescent assays for ligand-receptor interactions.
    Handl HL; Gillies RJ
    Life Sci; 2005 Jun; 77(4):361-71. PubMed ID: 15894006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.
    Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
    Anal Biochem; 2005 Aug; 343(2):299-307. PubMed ID: 16004955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based beta2-adrenergic receptor-ligand binding assay using synthesized europium-labeled ligands and time-resolved fluorescence.
    Martikkala E; Lehmusto M; Lilja M; Rozwandowicz-Jansen A; Lunden J; Tomohiro T; Hänninen P; Petäjä-Repo U; Härmä H
    Anal Biochem; 2009 Sep; 392(2):103-9. PubMed ID: 19464246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.
    De Silva CR; Vagner J; Lynch R; Gillies RJ; Hruby VJ
    Anal Biochem; 2010 Mar; 398(1):15-23. PubMed ID: 19852924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
    Veiksina S; Kopanchuk S; Rinken A
    Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
    Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
    Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
    Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
    Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies.
    Mazor O; Hillairet de Boisferon M; Lombet A; Gruaz-Guyon A; Gayer B; Skrzydelsky D; Kohen F; Forgez P; Scherz A; Rostene W; Salomon Y
    Anal Biochem; 2002 Feb; 301(1):75-81. PubMed ID: 11811969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
    Alleti R; Vagner J; Dehigaspitiya DC; Moberg VE; Elshan NG; Tafreshi NK; Brabez N; Weber CS; Lynch RM; Hruby VJ; Gillies RJ; Morse DL; Mash EA
    Bioorg Med Chem; 2013 Sep; 21(17):5029-38. PubMed ID: 23890524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-based peptide screening using ligand peptides directly conjugated to a thiolated glass surface.
    Lim CH; Cho HM; Choo J; Neff S; Jungbauer A; Kumada Y; Katoh S; Lee EK
    Biomed Microdevices; 2009 Jun; 11(3):663-9. PubMed ID: 19142733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of lanthanide-labeled human INSL3 as an alternative probe to radioactively labeled INSL3 for use in bioassays.
    Shabanpoor F; Hughes RA; Bathgate RA; Separovic F; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():87-90. PubMed ID: 19416164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
    Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
    Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europium-labeled melanin-concentrating hormone analogues: ligands for measuring binding to melanin-concentrating hormone receptors 1 and 2.
    Gao X; Hsu CK; Heinz LJ; Morin J; Shi Y; Shukla NK; Smiley DL; Xu J; Zhong B; Slieker LJ
    Anal Biochem; 2004 May; 328(2):187-95. PubMed ID: 15113696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic evidence for tandemly arranged ligand binding sites in melanocortin 4 receptor complexes.
    Kopanchuk S; Veiksina S; Mutulis F; Mutule I; Yahorava S; Mandrika I; Petrovska R; Rinken A; Wikberg JE
    Neurochem Int; 2006 Oct; 49(5):533-42. PubMed ID: 16764968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
    Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
    Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.